Halvio Capital Q4 2025 Letter To Partners

Halvio Capital returned 5.62 percent this quarter while exploring international value opportunities. View our latest partner ...
Kauppalehti

MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...

The AI Revolution Is Shrinking: Why Bigger Isn’t Always Better, Especially in Manufacturing

As manufacturers embrace Industry 4.0, smart factories and connected operations, a different reality is emerging: smaller, ...
Interesting Engineering

Building tomorrow’s factory: 5 digital upgrades every plant needs

Explore 5 essential digital upgrades powering smart factories—from ERP and MES to Digital Twins and AR - boosting efficiency, ...
Food Engineering

Rebellyous Foods Commercially Launches Mock 3 Production System

The system converts conventional batch production of plant-based meat substrates into fully continuous and automated ...